MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical Announces Preliminary 2011 Operating Results and Provides 2012 Net Revenue Guidance SHENZHEN, China, January 9, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2011. The company also provided net revenue guidance for 2012. For the] [Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline SHENZHEN, China, Jan 9, 2012 /PRNewswire via COMTEX/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2011 and its product pipeline for domestic and international markets in 2012. New product summary]

MR [Mindray Medical International] 6-K: Mindray Medical Announces Preliminary 2011 Operating Results and

[Mindray Medical Announces Preliminary 2011 Operating Results and Provides 2012 Net Revenue Guidance SHENZHEN, China, January 9, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2011. The company also provided net revenue guidance for 2012. For the] [Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline SHENZHEN, China, Jan 9, 2012 /PRNewswire via COMTEX/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2011 and its product pipeline for domestic and international markets in 2012. New product summary]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical Announces Preliminary 2011 Operating Results and Provides 2012 Net Revenue Guidance SHENZHEN, China, January9, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December31, 2011. Thempanyso provided net revenue guidance for 2012.] [Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline SHENZHEN, China, Jan 9, 2012 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2011 and its product pipeline for domestic and international markets in 2012.]

MR [Mindray Medical International] 6-K: Mindray Medical Announces Preliminary 2011 Operating Results and

[Mindray Medical Announces Preliminary 2011 Operating Results and Provides 2012 Net Revenue Guidance SHENZHEN, China, January9, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December31, 2011. Thempanyso provided net revenue guidance for 2012.] [Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline SHENZHEN, China, Jan 9, 2012 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2011 and its product pipeline for domestic and international markets in 2012.]

MR [Mindray Medical International] 6-K: Mindray Medical Announces Preliminary 2011 Operating Results and

[Mindray Medical Announces Preliminary 2011 Operating Results and Provides 2012 Net Revenue Guidance SHENZHEN, China, January9, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December31, 2011. Thempanyso provided net revenue guidance for 2012.] [Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline SHENZHEN, China, Jan 9, 2012 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2011 and its product pipeline for domestic and international markets in 2012.]

MR [Mindray Medical International] S-8: (Original Filing)

[] [MINDRAY MEDICAL INTERNATIONAL LIMITED SHARE INCENTIVE PLAN PREFACE This Plan is divided into two separate equity programs: (1) the option grant program set forth in Section 5 under which Eligible Persons (as defined in Section 3) may, at the discretion of the Administrator, be granted Options, and (2) the share award program set forth in Section 6 under which Eligible] [January 5, 2012 Mindray Medical International Limited Mindray Building Keji 12 th Road South Hi-tech Industrial Park Nanshen Shenzhen 518057 People’s Republic of China (852) 2842 9556 Christopher.Bickley@conyersdill.com Dear Sirs, Mindray Medical International Limited (the “Company”) Commission Registration Statement Securities Act Ordinary Shares Plan Resolutions Certificate Date For the purposes of giving this opinion, we have examined copies of the] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated April 8, 2011 relating to the financial statements, financial statements schedules and the effectiveness of internal control over financial reporting, which appears in Mindray Medical International Limited’s Annual Report on Form 20-F for the]

MR [Mindray Medical International] S-8:

[] [MINDRAY MEDICAL INTERNATIONAL LIMITED SHARE INCENTIVE PLAN PREFACE This Plan is divided into two separate equity programs: (1) the option grant program set forth in Section 5 under which Eligible Persons (as defined in Section 3) may, at the discretion of the Administrator, be granted Options, and (2) the share award program set forth in Section 6 under which Eligible] [January 5, 2012 Mindray Medical International Limited Mindray Building Keji 12 th Road South Hi-tech Industrial Park Nanshen Shenzhen 518057 People’s Republic of China (852) 2842 9556 Christopher.Bickley@conyersdill.com Dear Sirs, Mindray Medical International Limited (the “Company”) Commission Registration Statement Securities Act Ordinary Shares Plan Resolutions Certificate Date For the purposes of giving this opinion, we have examined copies of the] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated April 8, 2011 relating to the financial statements, financial statements schedules and the effectiveness of internal control over financial reporting, which appears in Mindray Medical International Limited’s Annual Report on Form 20-F for the]

MR [Mindray Medical International] S-8: (Original Filing)

[CALCULATION OF REGISTRATION FEE TitleofSecurities ToBeRegistered Amount ToBe Registered Proposed Maximum OfferingPrice Per Share STYLE="font-family:Times New Roman" SIZE="1"> Proposed Maximumgregate OfferingPrice AmountOf RegistrationFee ClassA Ordinary Shares, par value HK$0.001 per share, issuable under the Mindray Medical International Limited Shareentive Plan 6,000,000 Class A Ordinary Shares STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(3) US$25.72] [MINDRAY MEDICAL INTERNATIONAL LIMITED STYLE="font-family:Times New Roman" SIZE="2"> SHAREENTIVE PLAN PREFACE STYLE="font-family:Times New Roman" SIZE="2">This Plan is divided into two separate equity programs: (1)the option grant program set forth in Section5 under which Eligible Persons (as defined in Section3) may, at the discretion of theministrator, be granted Options, and (2)the share award program set forth] [STYLE="font-family:Times New Roman" SIZE="2">January 5, 2012 Mindray Medical International Limited Mindray Building Keji 12 th Road South Hi-tech Industrial Park Nanshen Shenzhen 518057 Peoples Republic of China (852) 2842 9556 STYLE="font-family:Times New Roman" SIZE="1">Christopher.Bickley@conyersdill.com Dear Sirs, Mindray Medical International Limited (thempany)mmission Registration Statement Securities Act Ordinary Shares Plan Resolutions] [STYLE="font-family:Times New Roman" SIZE="2">NSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in this Registration Statement on Form S-8 of our reportted April 8, 2011 relating to the financial statements, financial statementshedules and the effectiveness of internalntrol over financial reporting, which appears in Mindray Medical International Limiteds Annual Report on Form]

MR [Mindray Medical International] S-8: CALCULATION OF REGISTRATION FEE TitleofSecurities ToBeRegistered Amount ToBe

[CALCULATION OF REGISTRATION FEE TitleofSecurities ToBeRegistered Amount ToBe Registered Proposed Maximum OfferingPrice Per Share STYLE="font-family:Times New Roman" SIZE="1"> Proposed Maximumgregate OfferingPrice AmountOf RegistrationFee ClassA Ordinary Shares, par value HK$0.001 per share, issuable under the Mindray Medical International Limited Shareentive Plan 6,000,000 Class A Ordinary Shares STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(3) US$25.72] [MINDRAY MEDICAL INTERNATIONAL LIMITED STYLE="font-family:Times New Roman" SIZE="2"> SHAREENTIVE PLAN PREFACE STYLE="font-family:Times New Roman" SIZE="2">This Plan is divided into two separate equity programs: (1)the option grant program set forth in Section5 under which Eligible Persons (as defined in Section3) may, at the discretion of theministrator, be granted Options, and (2)the share award program set forth] [STYLE="font-family:Times New Roman" SIZE="2">January 5, 2012 Mindray Medical International Limited Mindray Building Keji 12 th Road South Hi-tech Industrial Park Nanshen Shenzhen 518057 Peoples Republic of China (852) 2842 9556 STYLE="font-family:Times New Roman" SIZE="1">Christopher.Bickley@conyersdill.com Dear Sirs, Mindray Medical International Limited (thempany)mmission Registration Statement Securities Act Ordinary Shares Plan Resolutions] [STYLE="font-family:Times New Roman" SIZE="2">NSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in this Registration Statement on Form S-8 of our reportted April 8, 2011 relating to the financial statements, financial statementshedules and the effectiveness of internalntrol over financial reporting, which appears in Mindray Medical International Limiteds Annual Report on Form]

MR [Mindray Medical International] S-8: CALCULATION OF REGISTRATION FEE TitleofSecurities ToBeRegistered Amount ToBe

[CALCULATION OF REGISTRATION FEE TitleofSecurities ToBeRegistered Amount ToBe Registered Proposed Maximum OfferingPrice Per Share Proposed Maximumgregate OfferingPrice AmountOf RegistrationFee ClassA Ordinary Shares, par value HK$0.001 per share, issuable under the Mindray Medical International Limited Shareentive Plan 6,000,000 Class A Ordinary Shares (1)(3) US$25.72 (2) US$154,320,000 (2) US$17,685.08 (2) (1)] [MINDRAY MEDICAL INTERNATIONAL LIMITED SHAREENTIVE PLAN PREFACE This Plan is divided into two separate equity programs: (1)the option grant program set forth in Section5 under which Eligible Persons (as defined in Section3) may, at the discretion of theministrator, be granted Options, and (2)the share award program set forth in Section6 under which Eligible Persons may,] [January 5, 2012 Mindray Medical International Limited Mindray Building Keji 12 th Road South Hi-tech Industrial Park Nanshen Shenzhen 518057 Peoples Republic of China (852) 2842 9556 Christopher.Bickley@conyersdill.com Dear Sirs, Mindray Medical International Limited (thempany)mmission Registration Statement Securities Act Ordinary Shares Plan Resolutions Certificatete For the purposes of giving this opinion, we have examinedpies of] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in this Registration Statement on Form S-8 of our reportted April 8, 2011 relating to the financial statements, financial statementshedules and the effectiveness of internalntrol over financial reporting, which appears in Mindray Medical International Limiteds Annual Report on Form 20-F for the]

Skip to toolbar